TRCT
NRXS icon

Tower Research Capital (TRC)’s Neuraxis NRXS Stock Holding History

Tower Research Capital (TRC)’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47K Buy
+1,159
New +$8.55K ﹤0.01% 4069
2026
Q1 		– Sell
-1,502
Closed -$6.82K – 5414
2025
Q4 		$6.82K Sell
1,502
-104
-6% -$311 ﹤0.01% 4046
2025
Q3 		$4.95K Sell
1,606
-539
-25% -$1.37K ﹤0.01% 4279
2025
Q2 		$5.19K Buy
2,145
+288
+16% +$675 ﹤0.01% 4218
2025
Q1 		$3.99K Sell
1,857
-457
-20% -$1.1K ﹤0.01% 4317
2024
Q4 		$5.44K Buy
2,314
+414
+22% +$1.16K ﹤0.01% 4290
2024
Q3 		$5.66K Sell
1,900
-1,610
-46% -$4.88K ﹤0.01% 4237
2024
Q2 		$9.76K Buy
3,510
+705
+25% +$2.15K ﹤0.01% 4211
2024
Q1 		$8.75K Sell
2,805
-1,171
-29% -$3.47K ﹤0.01% 3968
2023
Q4 		$10.6K Buy
3,976
+3,920
+7,000% +$10.6K ﹤0.01% 4222
2023
Q3 		$213 Buy
+56
New +$258 ﹤0.01% 5653

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Tower Research Capital (TRC)'s NRXS Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Neuraxis (NRXS) in Q2 2026: 1,159 shares worth $8.47K. The stake represents ﹤0.01% of the portfolio and ranks #4069 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in NRXS as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in NRXS in Q3 2023 and has held it in 11 quarters since. The position peaked at $10.6K in Q4 2023. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,159 shares of Neuraxis worth $8.47K as of Q2 2026.
  • Neuraxis was a new Tower Research Capital (TRC) position in Q2 2026.
  • Neuraxis made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4069 holding.
  • Tower Research Capital (TRC) first reported a position in Neuraxis in Q3 2023 and has held it in 11 quarters since.
  • Tower Research Capital (TRC)'s Neuraxis position peaked at $10.6K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.